Table 1.
Detection of antibodies by counterimmunoelectrophoresis and double immunodiffusion methods using a commercial antigen from Paracoccidioides spp.: evaluation of sera from patients with paracoccidioidomycosis or other diseases.
Detection of antibodies – N° of sera (%) |
|||||
---|---|---|---|---|---|
Disease type | CIEP |
DID |
Total | ||
Positive | Negative | Positive | Negative | ||
Paracoccidioidomycosis – active diseasea | 24 (100) | 0 (0) | 15 (63) | 9 (37) | 24 (100) |
Paracoccidioidomycosis in regression or clinical cureb | 15 (88) | 2 (12) | 15 (88) | 2 (12) | 17 (100) |
Histoplasmosis | 0 (0) | 7 (100) | 0 (0) | 7 (100) | 7 (100) |
Aspergillosis | 0 (0) | 5 (100) | 0 (0) | 5 (100) | 5 (100) |
Other diseasesc | 0 (0) | 27(100) | 0 (0) | 27 (100) | 27 (100) |
Patients without treatment or with up to three months of use of antifungals.
Patients with antifungal therapy higher than 3 months or already completed.
Patients without systemic fungal infection.
CIEP, counterimmunoelectrophoresis; DID, double immunodiffusion.